Clinical implications of mucosal healing for the management of IBD.

Nature Reviews. Gastroenterology & Hepatology
Guillaume Pineton de ChambrunJean-Frédéric Colombel

Abstract

Mucosal healing (MH) has emerged as an important treatment goal for patients with IBD. Historically, the therapeutic goals of induction and maintenance of clinical remission seemed insufficient to change the natural history of IBD. Evidence has now accumulated to show that MH can alter the course of IBD, as it is associated with sustained clinical remission, and reduced rates of hospitalization and surgical resection. In patients with ulcerative colitis, MH may represent the ultimate therapeutic goal because inflammation is limited to the mucosa. In patients with Crohn's disease, which is a transmural disease, MH could be considered as a minimum therapeutic goal. This Review focuses on the definition of MH and discusses the ability of each available IBD medication to induce and maintain MH. The importance of achieving MH is also discussed and literature that demonstrates improvement of disease course with MH is reviewed. Finally, we discuss how best to integrate the treatment end point of MH into clinical practice for the management of patients with IBD.

References

Jan 1, 1978·Scandinavian Journal of Gastroenterology·J Powell-TuckJ E Lennard-Jones
Apr 1, 1990·Ceskoslovenská pediatrie·A Kolek
Oct 1, 1990·Gastroenterology·P RutgeertsM Hiele
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Nov 1, 1966·The American Journal of Digestive Diseases·R Wright, S R Truelove
Jul 1, 1995·Scandinavian Journal of Gastroenterology·P MunkholmV Binder
Feb 2, 1995·The New England Journal of Medicine·B G FeaganM Hopkins
Oct 1, 1995·Alimentary Pharmacology & Therapeutics·M LémannR Modigliani
Oct 28, 1999·Gastrointestinal Endoscopy·G D'HaensP Rutgeerts
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·F CarbonnelJ P Gendre
Mar 6, 2002·Alimentary Pharmacology & Therapeutics·H MalchowUNKNOWN CLAFOAM Study group
Apr 23, 2002·Alimentary Pharmacology & Therapeutics·I D R ArnottS Ghosh
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
May 10, 2003·The American Journal of Gastroenterology·Robert BaldassanoHarland S Winter
Jun 6, 2003·Alimentary Pharmacology & Therapeutics·R SostegniA Pera
Aug 14, 1954·British Medical Journal·S C TRUELOVE, L J WITTS

❮ Previous
Next ❯

Citations

Oct 5, 2010·Current Gastroenterology Reports·Christina Ha, Asher Kornbluth
Mar 1, 2013·Inflammatory Bowel Diseases·Laura RosenbergAlan C Moss
Jan 4, 2013·Current Opinion in Gastroenterology·Matthew A Ciorba
Jun 8, 2011·Gut·Laurent Peyrin-BirouletUNKNOWN International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group
Apr 5, 2012·Diagnostic and Therapeutic Endoscopy·Matthew J Hamilton
Jun 3, 2010·World Journal of Gastroenterology : WJG·Matthieu Allez, Marc Lémann
Aug 10, 2012·World Journal of Gastroenterology : WJG·Giovanni Latella, Claudio Papi
Nov 28, 2013·World Journal of Gastroenterology : WJG·Julia LiuHelmut Neumann
Mar 8, 2013·World Journal of Gastroenterology : WJG·Vincenzo VillanacciGabrio Bassotti
Mar 16, 2011·World Journal of Gastrointestinal Endoscopy·Alfredo J Lucendo, Danila Guagnozzi
Apr 4, 2014·World Journal of Gastroenterology : WJG·Talia Zenlea, Mark A Peppercorn
May 8, 2014·World Journal of Gastroenterology : WJG·Burton I KorelitzGeorgia Panagopoulos
Dec 19, 2013·Nature Reviews. Gastroenterology & Hepatology·Christina Y Ha, Seymour Katz
Mar 13, 2014·BMC Gastroenterology·Chang-Qing LiYan-Qing Li
Apr 2, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·H AliC-M Lehr
Dec 19, 2013·Nature Reviews. Gastroenterology & Hepatology·Mark E Gerich, Dermot P B McGovern
May 20, 2014·Digestive Diseases and Sciences·Sun Mie YimJae Hee Cheon
May 20, 2014·Digestive Diseases and Sciences·Duk Hwan KimJae Hee Cheon
Aug 12, 2014·Gastroenterology Clinics of North America·Mark A SamaanBarrett G Levesque
Jun 5, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Armelle ChauvinAurelien Amiot
Jul 16, 2014·The Journal of Experimental Medicine·Randy S LongmanDan R Littman
Oct 1, 2014·Colloids and Surfaces. B, Biointerfaces·Muhammad NaeemJin-Wook Yoo
Mar 20, 2012·Journal of Crohn's & Colitis·Renzo CaprilliGiuseppe Frieri
Nov 5, 2013·Journal of Crohn's & Colitis·Vito AnneseUNKNOWN European Crohn's and Colitis Organisation
Sep 24, 2011·Journal of Crohn's & Colitis·Marco DapernoUNKNOWN Scientific Committee of the European Crohn's and Colitis Organization
Jul 27, 2011·Current Gastroenterology Reports·Joseph H Sellin
Jan 29, 2013·Current Gastroenterology Reports·Camille Zallot, Laurent Peyrin-Biroulet
Feb 1, 2013·Clinical Journal of Gastroenterology·Jun KatoMasao Ichinose
Oct 18, 2013·Scandinavian Journal of Gastroenterology·Klaudia FarkasTamás Molnár
Mar 22, 2014·Expert Review of Gastroenterology & Hepatology·Gian Eugenio TontiniHelmut Neumann
Aug 27, 2015·Expert Review of Clinical Pharmacology·Qi Ying LeanRahul P Patel
Nov 13, 2015·Expert Opinion on Drug Safety·Itishree Trivedi, Stephen B Hanauer
Oct 6, 2012·Expert Opinion on Drug Delivery·Bo Xiao, Didier Merlin
Apr 21, 2010·Expert Opinion on Emerging Drugs·Ulrike Strauch, Jürgen Schölmerich
Feb 22, 2016·Journal of Gastroenterology·Shapur IkhtaireWaliul Islam Khan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here